» Articles » PMID: 2742442

Changing Spectrum of Hemoptysis. Underlying Causes in 148 Patients Undergoing Diagnostic Flexible Fiberoptic Bronchoscopy

Overview
Journal Arch Intern Med
Specialty General Medicine
Date 1989 Jul 1
PMID 2742442
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

A retrospective study to examine the underlying causes of hemoptysis in patients undergoing diagnostic bronchoscopy was conducted. We found hemoptysis to be caused by bronchitis in 55 (37%) of 148, bronchogenic carcinoma in 28 (19%) of 148, tuberculosis in 10 (7%) of 148, and bronchiectasis in 1 (1%) of 148 patients. Compared with previous studies, it appears that hemoptysis is less likely to be caused by bronchiectasis or tuberculosis while hemoptysis caused by bronchitis has increased proportionately. The rate of occurrence of hemoptysis caused by bronchogenic carcinoma has not changed significantly. All patients with underlying bronchogenic carcinoma had a positive smoking history and abnormal chest roentgenogram. The rate of hemoptysis was not a good indicator of the underlying disease.

Citing Articles

Treatment of Massive Hemoptysis with Repeated Doses of Nebulized Tranexamic Acid.

Cutshall D, Inman B, Myers M Cureus. 2022; 14(9):e29625.

PMID: 36321025 PMC: 9605738. DOI: 10.7759/cureus.29625.


Management of life-threatening hemoptysis in the ICU.

Charya A, Holden V, Pickering E J Thorac Dis. 2021; 13(8):5139-5158.

PMID: 34527355 PMC: 8411133. DOI: 10.21037/jtd-19-3991.


Inhaled Tranexamic Acid for Non-Massive Haemoptysis in a Rivaroxaban-Receiving Patient Not Responding to the Oral Form.

Eltahir M, Elshafei M, Elzouki A Eur J Case Rep Intern Med. 2021; 7(12):001930.

PMID: 33585326 PMC: 7875595. DOI: 10.12890/2020_001930.


Efficacy, safety and usability of bronchial artery embolization using a new anti-reflux microcatheter in the management of haemoptysis.

Angileri S, Roda G, Arrichiello A, Signorelli G, Di Meglio L, Gurgitano M Acta Biomed. 2020; 91(10-S):e2020009.

PMID: 33245068 PMC: 8023073. DOI: 10.23750/abm.v91i10-S.10265.


Management of life-threatening hemoptysis.

Kathuria H, Hollingsworth H, Vilvendhan R, Reardon C J Intensive Care. 2020; 8:23.

PMID: 32280479 PMC: 7132983. DOI: 10.1186/s40560-020-00441-8.